cefuroxime axetil ( cae ) , an orally absorbed prodrug of cefuroxime , was evaluated for its efficacy and safety in the treatment of upper respiratory tract infections ( tonsillitis , pharyngitis , sinusitis and otitis media ) in general practice in the united kingdom .
C0007562
cefuroxime
C0037199
sinusitis